About Us
Theragnostic Technologies is seed stage biomedical company focusing on research and development of high performance multifunctional nanotechnology-enabled materials and devices. Founded in 2012, it is a participant of StartUp NY, and situated at the Long Island High Technology Incubator on the campuses of Stony Brook University.
Vision:
To be a leader in providing innovative solutions that advance healthcare and improve quality of life.
Mission:
To offer range of cutting-edge biomedical and healthcare products to improve imaging, therapy and tissue regeneration.
Core Competency:
Materials, tools and methods at the interface of nanotechnology and biomedical science and engineering.
Shahram Hejazi, PhD
Director
-
Entrepreneur and board member of early-stage and large global life science and biotech companies
-
20+ years of executive management experience in diagnostic and imaging technologies
-
Venture Partner with BioAdvance Philadelphia
Our Advisors
John Haley, PhD
Business Advisor
-
25+ years of diverse experience as life science executive
-
Deep knowledge of exploratory, discovery, and translational issues
-
Director, Developmental Therapeutics and Proteomics Center and Faculty of Pathology Department, Stony Brook University
Susan Wilson, DVM, PhD
Regulatory Advisor
-
Regulatory expert across drug products and imaging agents
-
Ex-FDA pharmacology/toxicology reviewer
-
Founding partner, VP and Chief Scientific Officer of Aclairo pharmaceutical development group
Gaurav Lalwani, PhD
Product Development
-
Expertise in carbon nanomaterial platforms for biomedical applications
-
Knowledge of IP and regulatory due diligence matters
-
Experience in product and business development process
Cheryl Springfels
Business Strategist
-
20+ years of strategic consulting for the nations top non-profits, scientific and educational institutions
-
10+ years of experience helping researchers bring biomedical products to market
Our Team
Balaji Sitharaman, PhD
Founder and Director
-
Inventor of ManGraDex
-
Internationally Recognized for MRI Contrast Agent R&D
-
Over 15 years of experience and expertise in carbon nanotechnology
-
Director of Multifunctional Nanobiosystems Laboratory
-
Biomedical Engineering Faculty at Stony Brook University
Full Profile >
Bob Williams
Interim CEO
-
25+ years of product develop, management and business development experience in diagnostic imaging technologies
-
Past Business unit responsibility for medical devices, consumables, and healthcare IT product lines
-
Former business development and innovation executive at ACIST Medical Systems and Bracco Imaging SpA
-
Consultant and advisor to various Med-Tech clients
-
Entrepreneur mentor and Angel investor
Dennis Fujii, PhD
Director
-
25+ years of senior management experience in diagnostic and imaging technologies
-
Ex-Director at Bracco Imaging and Nycomed-Amersham Imaging
-
Deep knowledge of R&D for imaging agents
Jimmy Toussaint, PhD
Senior Scientist and Vice President of Research
-
13+ years R&D experience in bioimaging and regenerative medicine
-
Recipient of small business grants on graphene technologies
-
Broad knowledge of translational pathway of imaging agents
Scientific Advisory Board
Kenneth Shroyer, MD, PhD
Marvin Kuschner Professor and Chair, Department of Pathology at Stony Brook University
-
Expert in toxicology and pharmacology of nanoparticles
-
Nationally recognized clinical pathologist
William Moore, MD
Chief of Cardiovascular and Thoracic Imaging at Stony Brook University
-
Experience in MRI protocols
-
Broad knowledge in contrast agents for various imaging modalities
Sandeep Mallipattu, MD
Physician Scientist in Nephrology, Stony Brook University
-
Experience in animal models of kidney disease and injury
-
Indepth knowledge of clinical issue related to renal failure diagnosis and imaging